Description

n-(5,6-Dihydro-6-Methyl-2-Sulfamoyl-4H-Thieno[2,3-B]Thiopyran-4-Yl)Acetamide 7,7-Dioxide is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure containing a sulfamoyl group and a thienothiopyran core. This compound is of significant value in the research and development of novel therapeutic agents, particularly due to its potential as a key building block in medicinal chemistry. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of new chemical entities (NCEs) for drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of potential active pharmaceutical ingredients (APIs) for new drug candidates.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies in drug discovery, particularly for targets involving sulfonamide-based inhibitors.
• Biochemical Research: May be utilized in the development of enzyme inhibitors or receptor modulators for investigative purposes.
• Fine Chemical Synthesis: Employed in multi-step organic synthesis to create more complex molecules for specialized applications.
• Reference Standard: Can be supplied as a high-purity analytical standard for quality control and method development in analytical laboratories.

Basic Information

Item	Details
Product Name	n-(5,6-Dihydro-6-Methyl-2-Sulfamoyl-4H-Thieno[2,3-B]Thiopyran-4-Yl)Acetamide 7,7-Dioxide
CAS No.	120298-38-6
Molecular Formula	C11H14N2O4S3
Molecular Weight	334.43 g/mol
Synonyms	4-Acetamido-6-methyl-2-sulfamoyl-4H-thieno[2,3-b]thiopyran 7,7-dioxide; 4-Acetylamino-6-methyl-2-sulfamoyl-4H-thieno[2,3-b]thiopyran 7,7-dioxide; N-(6-Methyl-2-sulfamoyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl)acetamide; Acetamide, N-(5,6-dihydro-6-methyl-2-sulfamoyl-4H-thieno[2,3-b]thiopyran-4-yl)-, 7,7-dioxide
EINECS	Contact for details

Quality Control

Our n-(5,6-Dihydro-6-Methyl-2-Sulfamoyl-4H-Thieno[2,3-B]Thiopyran-4-Yl)Acetamide 7,7-Dioxide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider conditions under an inert atmosphere to ensure stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Assay	97.0% - 102.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.